Press Releases

Date	Title
April 5, 2023	Corcept Therapeutics Announces Final Results of Tender Offer
April 3, 2023	Corcept Therapeutics Announces Preliminary Results of Tender Offer
March 28, 2023	Corcept Therapeutics Initiates CATALYST Clinical Trial
March 6, 2023	Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock
February 28, 2023	Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update
February 14, 2023	Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call
February 13, 2023	Corcept Therapeutics Announces Preliminary Settlement of Purported Securities Class Action Litigation